Influence of calcitriol on prostaglandin- and vitamin D-metabolising enzymes in benign and malignant breast cell lines.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Anticancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 22213327
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer.

  2011cited by this paper
• Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines

  2011cited by this paper
• A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer

  2011cited by this paper
• Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk.

  2011cited by this paper
• Vitamin D in combination cancer treatment

  2010cited by this paper
• Prostaglandin metabolising enzymes and PGE2 are inversely correlated with vitamin D receptor and 25(OH)2D3 in breast cancer.

  2010cited by this paper
• Prostaglandin metabolizing enzymes in correlation with vitamin D receptor in benign and malignant breast cell lines.

  2009cited by this paper
• CCAAT Enhancer-binding Protein α Is a Molecular Target of 1,25-Dihydroxyvitamin D3 in MCF-7 Breast Cancer Cells*

  2009cited by this paper
• Vitamin D intake and breast cancer risk: a case-control study in Italy.

  2009cited by this paper
• Reduced risk of bone metastasis for patients with breast cancer who use COX-2 inhibitors.

  2009cited by this paper
• Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study

  2009cited by this paper
• Treatment of advanced hormone-sensitive breast cancer in postmenopausal women with exemestane alone or in combination with celecoxib.

  2008cited by this paper
• Inflammation and cancer: Role of nuclear factor‐kappaB activation

  2008cited by this paper
• Selective inhibition of cyclooxygenase‐2 (COX‐2) by 1α,25‐dihydroxy‐16‐ene‐23‐yne‐vitamin D3, a less calcemic vitamin D analog

  2008cited by this paper
• Calcitriol as a Chemopreventive and Therapeutic Agent in Prostate Cancer: Role of Anti‐Inflammatory Activity

  2007cited by this paper
• A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells

  2006cited by this paper
• Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D.

  2006cited by this paper
• Promise of vitamin D analogues in the treatment of hyperproliferative conditions

  2006cited by this paper
• Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.

  2005cited by this paper
• Regression of Mouse Prostatic Intraepithelial Neoplasia by Nonsteroidal Anti-inflammatory Drugs in the Transgenic Adenocarcinoma Mouse Prostate Model

  2004cited by this paper
• Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy

  2004cited by this paper
• Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemoprevention.

  2004cited by this paper
• Effects of Seocalcitol (EB1089) on Nitrosomethyl Urea-Induced Rat Mammary Tumors

  2003cited by this paper
• Vitamin D-3 receptor as a target for breast cancer prevention.

  2003cited by this paper
• Vitamin D in preventive medicine: are we ignoring the evidence?

  2003cited by this paper
• Vitamin D Growth Inhibition of Breast Cancer Cells: Gene Expression Patterns Assessed by cDNA Microarray

  2003cited by this paper
• Cyclooxygenase-2 and prostate carcinogenesis.

  2003cited by this paper
• Effect of cyclooxygenase-2 (COX-2) inhibitors on prostate cancer cell proliferation.

  2003cited by this paper
• Elevated expression of cyclooxygenase‐2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma

  2003cited by this paper
• Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer.

  2002cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro

  1998cited by this paper
• Prostaglandin endoperoxide synthase: why two isoforms?

  1996cited by this paper
• 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.

  1995cited by this paper
• 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.

  1983cited by this paper

• Combinations of Calcitriol with Anticancer Treatments for Breast Cancer: An Update

  2021cites this paper
• Differential Impact of Calcitriol and Its Analogs on Tumor Stroma in Young and Aged Ovariectomized Mice Bearing 4T1 Mammary Gland Cancer

  2020cites this paper
• Vitamin D und Brustkrebs: Was gibt es Neues?

  2019cites this paper
• Effects of Combined Treatment with Vitamin D and COX2 Inhibitors on Breast Cancer Cell Lines.

  2018cites this paper
• Identification of potential new treatment response markers and therapeutic targets using a Gaussian process-based method in lapatinib insensitive breast cancer models

  2017cites this paper
• Combined treatment of breast cancer cell lines with vitamin D and COX-2 inhibitors.

  2015cites this paper
• Vitamin D inhibits ovarian cancer cell line proliferation in combination with celecoxib and suppresses cyclooxygenase-2 expression.

  2015cites this paper
• The Effect of Vitamin D3 on Hepcidin and IL-8 Expression in Monocytes

  2013cites this paper